Glycogenesys

Glycogenesys was a biotechnology company specializing in carbohydrate-based drugs. They were pioneering new treatments for serious gastrointestinal diseases, all of which were based on the glucose molecule.

Unfortunately, Glycogenesys went bankrupt. The extensive research that went into developing their pharmaceutical treatments is now being utilized elsewhere.

Glycogenesys are not the only company to have developed carbohydrate-based therapies, however. Carbohydrates play a fundamental role in cellular functioning, and by extension they are involved in serious disease pathologies (particularly those dependent on inflammation).

Many companies are utilizing the unique structural complexity of carbohydrates to develop novel treatments and drugs for complex conditions, from diabetes to tests for acute heart failure.

Organic, plant-based solutions

The interest in developing carbohydrate-based pharmaceuticals is indicative of a general trend in biotechnology, biohacking, healthcare, and nutrition more broadly. We’re talking about the increasing focus on organic, preventative, natural (as opposed to synthetic) products.

The most popular supplements today are generally 100% plant-based.

Our top rated nootropics are vegan-friendly, and the vitamins and minerals used in these products are all grown on prebiotic fibers.

Our favorite supplements all utilize plant-based, prebiotic capsules for delivery.

Take a look at some of our top rated products and see if any can meet your needs.